Product information

Ibrance 125 mg
21
palbociclib
3523644
0 / 10
Locked

Product properties

571190-30-2
L01EF01
Pfizer Europe MA
Capsule, hard, Capsule, hard
€3,820.11
EU/1/16/1147/005
05415062301180
M44
Public
504195-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Replacement by another medicinal product/pack) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

No status history available.

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
125 mg
571190-30-2
Excipient
93 mg
Excipient
Excipient

Additional information

View on BCPI

Availability statistics

Unknown
0 days
0
0